Back
Denali Therapeutics Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
20
DNLI
Denali Therapeutics
Last Price:
$18.74
Seasonality Move:
-5.23%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.43 | Sell |
| 20-day SMA: | 21.23 | Sell |
| 50-day SMA: | 24.21 | Sell |
| 200-day SMA: | 23.06 | Sell |
| 8-day EMA: | 20.33 | Sell |
| 20-day EMA: | 21.33 | Sell |
| 50-day EMA: | 23.24 | Sell |
| 200-day EMA: | 23.67 | Sell |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.17 | Sell |
| Relative Strength Index (14 RSI): | 36.96 | Sell |
| Chaikin Money Flow: | 739587 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.2 - 23.5) | Sell |
| Bollinger Bands (100): | (22.63 - 28.75) | Sell |
Denali Therapeutics Technical Analysis
| Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 19.59 while DNLI 8-day simple moving average is 20.43, which is a Sell signal.
-
The stock price of DNLI is 19.59 while Denali Therapeutics 20-day SMA is 21.23, which makes it a Sell.
-
Denali Therapeutics 50-day simple moving average is 24.21 while DNLI share price is 19.59, making it a Sell technically.
-
DNLI stock price is 19.59 and Denali Therapeutics 200-day simple moving average is 23.06, creating a Sell signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
20
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a SellThe current Denali Therapeutics [DNLI] share price is $19.59. The Score for DNLI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
2.8B
Price in USD:
19.59
Share Volume:
840.4K
Denali Therapeutics 52-Week Range
52-Week High:
33.33
52-Week Low:
14.56
Sell
20
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?The Denali Therapeutics stock price is 19.59 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 19.59 while DNLI 8-day exponential moving average is 20.33, which is a Sell signal.
-
The stock price of DNLI is 19.59 while Denali Therapeutics 20-day EMA is 21.33, which makes it a Sell.
-
Denali Therapeutics 50-day exponential moving average is 23.24 while DNLI share price is 19.59, making it a Sell technically.
-
DNLI stock price is 19.59 and Denali Therapeutics 200-day simple moving average is 23.67, creating a Sell signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.79 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is -1.17, suggesting Denali Therapeutics is a Sell
-
Denali Therapeutics Relative Strength Index (RSI) is 36.96, which suggest Denali Therapeutics is oversold
-
The Bollinger Bands (25) for Denali Therapeutics is (20.2 - 23.5), which suggest Denali Therapeutics is a Sell
-
The Bollinger Bands (100) for Denali Therapeutics is (22.63 - 28.75), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.